MAPT and Alzheimer disease: The occurrence of AD is related to β-amyloid (Aβ) plaques and neurofibrillary tangles (containing tau protein) in the cerebral cortex and subcortical regions, so there is the speculation that the reducing or eliminating of this substance from the brain may prevent or reverse the progression of AD disease [4, 5].